Page last updated: 2024-08-25

erythromycin propionate-n-acetylcysteinate and Prostatic Neoplasms

erythromycin propionate-n-acetylcysteinate has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hoy, JJ; Iglesias-Bartolome, R; Kuhn, S; Park, J; Salinas Parra, N1

Other Studies

1 other study(ies) available for erythromycin propionate-n-acetylcysteinate and Prostatic Neoplasms

ArticleYear
Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:10

    Topics: Acetylcysteine; Animals; Cell Line, Tumor; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Erythromycin; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; GTP-Binding Protein alpha Subunits; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Prostatic Neoplasms

2020